Financials
Financial year 2024
LOVAFARMA from Leuven, company number BE0476540511, closed financial year 2024 with a result of € 137,154 after tax. For that financial year LOVAFARMA recorded a gross margin of € 219,175 and equity of € 491,458. Compared with financial year 2023, the result moved from € 12,365 to € 137,154. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 8, 2025.
€ 491,458
▲ 241% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 137,154
▲ € 124,788 vs 2023
Profit after tax over the fiscal year.
€ 165,785
▲ 58% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 275,258.
People and assets in 2024
€ 2,426
▼ 13% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 74,993
▼ 43% vs 2023
Loans from banks and other lenders, long and short.
€ 30,450
▼ 15% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 9,375
▼ 41% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 91,741 | € 122,403 | € 52,956 | € 219,175 | ▲ € 166,219 |
| Profit after taxes | € 45,749 | € 61,265 | € 12,365 | € 137,154 | ▲ € 124,788 |
| Equity | € 70,673 | € 131,938 | € 144,304 | € 491,458 | ▲ 241% |
| Total debts | € 276,115 | € 263,534 | € 248,622 | € 176,763 | ▼ 29% |
| Cash | € 77,304 | € 109,339 | € 104,754 | € 165,785 | ▲ 58% |
| Land & buildings | € 141,745 | € 124,259 | € 106,774 | € 306,479 | ▲ 187% |
| Retained profit | € 64,473 | € 125,738 | € 138,104 | € 275,258 | ▲ 99% |
| Bank debt | € 196,880 | € 162,139 | € 131,589 | € 74,993 | ▼ 43% |
| Balance sheet total | € 346,788 | € 395,472 | € 392,926 | € 715,998 | ▲ 82% |
Key figures of LOVAFARMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to LOVAFARMA?
What happened at LOVAFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 137,154 (▲ € 124,788 vs 2023). filed late Source: NBB ↗
- DELCLE BV became a director. NBB
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 45,749 profit in 2021 to € 137,154 profit in 2024.
Paid € 39,248 in corporate taxes since 2021.
Best year ever: 2024, with € 137,154 profit.
A new publication or filing at LOVAFARMA? We notify you, reason included.
Follow LOVAFARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DELCLE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LOVAFARMABehind LOVAFARMA is DELCLE BV. The shares are held by DELCLE (100%).
Establishments
Establishment units
Physical locations of this company
Diestsesteenweg 133a box 101
3010 Leuven
Parijsstraat 63
3000 Leuven
Active since 16 December 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0476.540.511
- VAT number
- BE 0476.540.511
- Registered office
- Diestsesteenweg 133a bus 101, 3010 Leuven
- Names & denominations
- LOVAFARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 January 2002
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers